期刊文献+

经典三联抗HP治疗临床分析 被引量:1

下载PDF
导出
摘要 目的潘托拉唑、克拉霉素、阿莫灵经典三联抗HP治疗疗效观察。方法将128例门诊幽门螺杆菌感染(HP)感染的患者随机入组,使用潘托拉唑、克拉霉素、阿莫西林三联疗法;疗程为1周。抗菌疗程结束1个月后查14C呼气试验,检查HP根除状况。结果成功随访的126例,91例(72.2%)HP得到根除。其中溃疡患者99例,75例(75.8%)得到根除;其他27例,16例(59.2%)HP得到根除。两组根除率比较,差异有统计学意义(P<0.05)。结论在本地区潘托拉唑、克拉霉素、阿莫西林三联疗法的根除率达不到理想方案的要求,尤其对非溃疡HP阳性患者根除效果不理想。
出处 《中国医药指南》 2011年第21期329-330,共2页 Guide of China Medicine
  • 相关文献

参考文献8

  • 1Glupczynski Y, Megraud F, Lopez-Brea M,et al.European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori[J].Eur J Clin Microbiol Infect Dis,2001,20(11):820-823.
  • 2Lamouliatte H,Megraud F, Delchier JC,et al.Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies[J].Aliment Pharrnacol Ther, 2003,18(8):791-797.
  • 3成虹 胡伏莲.1ap耐药机制.中华消化杂志,2003,23(9):557-559.
  • 4Megraud F.Update on therapeutic options for Helicobacter pylori-related diseases[J].Curr Infect Dis Rep,2005,7(2): 115-120.
  • 5曹群奋,马海峰,陈勇华,车海斌.上消化道疾病患者幽门螺杆菌耐药情况分析[J].现代实用医学,2007,19(1):29-30. 被引量:4
  • 6De Francesco V, Zullo A,Margiotta M,et al.Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure[J].Aliment Pharmacol Ther,2004,19(4):407-414.
  • 7Zullo A,Vaira D,Vakil N,et al.High eradication rates of Helicob- aeter pylori with a new sequential treatment[J].Alirnent Pharmacol Ther,2003,17(5):719-726.
  • 8Ford A,Moayyedi P.How can the current strategies for Helicoba- cter pylori eradication therapy be improved? [J].Can J Gaslroenterol, 2003,17(Suppl B):36B-40B.

二级参考文献10

  • 1束庆文,娄诗金,刘太平,疏东升,汪全红,潘小龙,蔡善武,金小春,薛刚.奥美拉唑、左氧氟沙星、呋喃唑酮三联疗法治疗幽门螺杆菌感染[J].蚌埠医学院学报,2006,31(1):48-50. 被引量:15
  • 2刘义忠.幽门螺杆菌研究进展[M].上海:科学技术文献出版社,2001;104~133.
  • 3Debets OYJ,Pot RG,Van Weslerloo DJ,et al.Insertion of mini-IS605 and deletion of adjacent sequences in the rutroreductase (rdxA).gene cause metronidazole resistance in Helicobac ter pylori NCTC11637[J].Antimicrob Agents Chemother,1999,43 (11):2657-2662.
  • 4Debets-Ossenkopp YJ,Brinkman AB,Kuipers EJ,et al.Explaining the bias in the 23S Rrna gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori[J].Antimicrob Agents Chemother,1998,42(10):2749-2751.
  • 5Kwon DH,Dore MP,Kim JJ,et al.High-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori[J].An timicrob Agents Chemother,2003,47(7):2169-2178.
  • 6Okamoto T,Yoshiyama H,Nakazawa T,et al.A change in PBP1 is involved in amoxicillin resistance of Helicobacter pylori[J].J Antimicrob Chemother,2002,50(6):849-856.
  • 7Moore RA,Beckthold B,Wong S,et al.Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori[J].Antimicrob Agents Chemother,1995,39(1):107-111.
  • 8Kwon DH,Lee M,Kim JJ,et al.Furazolidone and nitrofurantoin-resistant Helicobacter pylori; prevalence and role of genes involved in metronidazole re sistance[J].Antimicrob Agents Chemother,2001,45(1):306-308.
  • 9姜葵,张建中,潘国宗.幽门螺杆菌耐药性检测[J].中国人兽共患病杂志,2000,16(6):76-78. 被引量:25
  • 10张万岱,萧树东,胡伏莲,林三仁,胡品津,刘文忠,王继德,徐智民.幽门螺杆菌共识意见(2003·安徽桐城)[J].中华消化杂志,2004,24(2):126-127. 被引量:439

共引文献3

同被引文献8

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部